Skip to main content
. 2019 Jan 5;95(3):187–192. doi: 10.1136/sextrans-2018-053705

Table 3.

Obtaining PreP and disclosure of PreP use to medical professionals

Country of residence On PrEP Where was PrEP obtained? n (%) Is your sexual health physician/doctor aware? n (%)
Physician Research study Internet Friend Taken as PEP Other Yes No
France* 281 175 (62.3) 32 (11.4) 15 (5.3) 21 (7.5) 20 (7.1) 24 (8.5) 170 (67.5) 82 (32.5)
Russia 195 30 (15.4) 8 (4.1) 30 (15.4) 23 (11.8) 4 (2.1) 4 (2.1) 38 (49.4) 39 (50.6)
UK*† 146 8 (5.5) 18 (12.3) 112 (76.7) 6 (4.1) 3 (2.1) 7 (4.8) 110 (78.0) 31 (22.0)
Italy 50 7 (14.0) 9 (18.0) 9 (18.0) 2 (4.0) 2 (4.0) 1 (2.0) 18 (69.2) 8 (30.8)
Turkey 99 13 (13.1) 6 (6.1) 16 (16.2) 14 (14.1) 7 (7.1) 5 (5.1) 28 (58.3) 20 (41.7)
Ukraine† 62 10 (16.1) 4 (6.5) 11 (17.7) 8 (12.9) 2 (3.2) 0 (0) 14 (66.7) 7 (33.3)
Germany‡ 30 5 (16.7) 2 (6.7) 13 (43.3) 4 (13.3) 1 (3.3) 3 (10.0) 13 (65.0) 7 (35.0)
Belgium* 19 9 (47.4) 4 (21.1) 1 (5.3) 1 (5.3) 0 (0) 3 (15.8) 13 (86.7) 2 (13.3)
Belarus 17 3 (17.6) 1 (5.9) 4 (23.5) 3 (17.6) 1 (5.9) 1 (5.9) 5 (50.0) 5 (50.0)
Spain 13 1 (7.7) 2 (15.4) 2 (15.4) 2 (15.4) 0 (0) 1 (7.7) 5 (83.3) 1 (16.7)
The Netherlands‡ 21 4 (19.0) 7 (33.3) 5 (23.8) 1 (4.8) 0 (0) 2 (9.5) 13 (72.2) 5 (27.8)
Denmark 14 3 (21.4) 5 (35.7) 1 (7.1) 3 (21.4) 0 (0) 1 (7.1) 12 (100) 0 (0)
Switzerland 8 5 (62.5) 0 (0) 5 (62.5) 0 (0) 0 (0) 0 (0) 4 (50.0) 4 (50.0)
Portugal* 6 1 (16.7) 1 (16.7) 2 (33.3) 2 (33.3) 1 (16.7) 0 (0) 4 (100) 0 (0)
Sweden 18 2 (11.1) 0 (0) 13 (72.2) 1 (5.6) 0 (0) 1 (5.6) 5 (29.4) 12 (70.6)
Other 92 25 (27.2) 9 (9.8) 27 (29.3) 17 (18.5) 3 (3.3) 7 (7.6) 34 (59.6) 23 (40.4)
Total 1071 301 (28.1) 108 (10.1) 266 (24.8) 108 (10.1) 44 (4.1) 60 (5.6) 486 (66.4) 246 (33.6)

Note in the case of UK, PrEP is available in the national health system in Scotland, only via demonstrations or clinical trials in England and Wales, and not available in Northern Ireland.

*PrEP available as part of the national health system at the time of survey.

†PrEP available to a limited extent through demonstration projects or clinical trials.

‡PrEP available at state-subsidised cost at the time of survey.

PrEP, pre-exposure prophylaxis.